KEY POINTS
  • Amazon is working with the Fred Hutchinson Cancer Research Center to develop cancer vaccines, according to a filing.
  • Amazon is listed as a collaborator on a filing for an FDA-approved clinical trial, which seeks to develop personalized vaccines to treat breast and skin cancers.

In this article

Andy Jassy, chief executive officer of Amazon.Com Inc., during the GeekWire Summit in Seattle, Washington, U.S., on Tuesday, Oct. 5, 2021.

Amazon is developing cancer vaccines in collaboration with the Fred Hutchinson Cancer Research Center, and it recently launched an FDA-approved clinical trial.

Amazon and Fred Hutchinson are looking to recruit 20 participants over the age of 18 for the early stage, or phase 1, trial, according to a filing on clinicaltrials.gov, a database of clinical trials run by the National Library of Medicine. The goal is to develop "personalized vaccines" that can treat breast cancer and melanoma, a form of skin cancer, the filing states.

In this article